CSL Seqirus announces Lancet publication on influenza vaccine
CSL Seqirus said a Phase 3 study was published in The Lancet showing benefits for older adults from a first influenza vaccine combining three proven approaches.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.